leisure time -WSS

leisure time

author：fashion 2025-09-30 14:10:09 - browse：617

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： How generative AI ratchets up security threats for health systems

WSS

FTC sues over Novant Health acquisition of two N.C. hospitals

Humana sues Biden admin over Medicare Advantage audit rule

The 10 drugs up first for Medicare price negotiation

ALS advocates say criticism of new drugs misses bigger picture

Why you shouldn’t ask, “What country has the best health care?”

'Make People Better': The CRISPR babies story you probably don't know

entertainment

leisure time

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

White House pharmacy plagued with problems, investigation finds

Tori Bowie and the unacceptable rates of Black maternal death

How to protect patients from sexual assault

After affirmative action ruling, medical educators look to 'holistic review'

Bernie Sanders is gearing up to subpoena pharma CEOs

Hollywood unions extend contract negotiations for actors

Snackable artificial intelligence, expert AI, and the pharma industry

Supreme Court strikes down use of affirmative action

Why Medicare shouldn’t cover every FDA

focus

10 reasons why health care startups fail

Philips to halt sales of sleep apnea machines in U.S.

Stem cell treatment guidelines are released by FDA

NIH nominee Bertagnolli will get October confirmation hearing

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Zyn nicotine pouches become unlikely player in latest culture war

explore

leisure time

knowledge

focus